BioSpace News Archive

Concordia International Corp. announced that at the meetings of holders of certain secured debt of Concordia approved the previously announced recapitalization transaction (the “Recapitalization Transaction”) to be implemented pursuant to a plan of arrangement under the Canada Business Corporations Act (the “CBCA”).

Claim Forms Due June 25, 2018

Key recommendations from LUNGevity’s Expanded Eligibility working group published in Journal of Thoracic Oncology

The organization will surpass $145 million in lifetime funding celebrating its 20th Year in ‘Saving Lives and Creating Hope’ to End Childhood Cancer

Caladrius Biosciences, Inc. announces today that that the U.S. Food and Drug Administration has granted RMAT designation to the Company’s late-stage CD34+ cell therapy program.

Varian announced the installation of a Varian ProBeam® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England.

Leading BioSciences today reported positive interim data from the company’s ongoing Phase 2 clinical trial of its lead drug candidate, LB1148.

The National Center for Learning Disabilities (NCLD) has selected Carmichael Lynch Relate as its new communications agency following a competitive search.

MMRF Honored for Fifteenth Year for Outstanding Stewardship of Donors’ Funds

Clean Recovery Centers has announced a partnership with Steve Maraboli (www.stevemaraboli.net) a life-changing speaker, author, and leading Behavioral Scientist.